Zogenix Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
72,021.00
50,705.00
165,351.00
91,551.00
293,503.00
514,187
Total Accounts Receivable
6,665.00
8,877.00
1,396.00
13,075.00
-
-
Inventories
9,936.00
13,439.00
12,030.00
7,047.00
-
-
Other Current Assets
4,255.00
4,957.00
5,726.00
8,241.00
11,200.00
18,543
Total Current Assets
92,877.00
77,978.00
184,503.00
119,914.00
304,703.00
532,730
Net Property, Plant & Equipment
13,011.00
10,618.00
9,254.00
1,710.00
245.00
2,870
Total Investments and Advances
200.00
-
-
-
-
-
Intangible Assets
-
108,734.00
108,734.00
108,734.00
108,734.00
108,734
Other Assets
6,416.00
5,505.00
3,331.00
1,147.00
3,931.00
3,997
Total Assets
112,504.00
204,010.00
306,722.00
231,505.00
417,613.00
648,805
ST Debt & Current Portion LT Debt
-
1,450.00
6,321.00
3,267.00
-
Accounts Payable
4,622.00
8,523.00
5,290.00
4,549.00
3,356.00
Other Current Liabilities
54,158.00
34,264.00
18,375.00
12,494.00
17,627.00
Total Current Liabilities
58,780.00
44,237.00
29,986.00
20,310.00
20,983.00
Long-Term Debt
29,035.00
21,703.00
15,899.00
18,824.00
-
Provision for Risks & Charges
-
53,000.00
51,371.00
52,800.00
76,900.00
Deferred Taxes
-
20,500.00
18,450.00
17,425.00
17,425.00
Other Liabilities
6,263.00
8,116.00
7,356.00
1,390.00
784.00
Total Liabilities
94,078.00
148,731.00
123,962.00
110,749.00
116,092.00
Common Equity (Total)
18,426.00
55,279.00
182,760.00
120,756.00
301,521.00
Total Shareholders' Equity
18,426.00
55,279.00
182,760.00
120,756.00
301,521.00
Total Equity
18,426.00
55,279.00
182,760.00
120,756.00
301,521.00
Liabilities & Shareholders' Equity
112,504.00
204,010.00
306,722.00
231,505.00
417,613.00

About Zogenix

View Profile
Address
5959 Horton Street
Emeryville California 94608
United States
Employees -
Website http://www.zogenix.com
Updated 07/08/2019
Zogenix, Inc. is a pharmaceutical compan. It engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include ZX008 and Relday.